Stockscreener 앱 받기
137.07
2.32%
-3.26
시간 외 거래:
137.07
전일 마감가:
$140.33
열려 있는:
$138
하루 거래량:
295.09K
Relative Volume:
0.87
시가총액:
$3.96B
수익:
$290.51M
순이익/손실:
$89.16M
주가수익비율:
45.84
EPS:
2.99
순현금흐름:
$119.18M
1주 성능:
+0.09%
1개월 성능:
+1.89%
6개월 성능:
-16.24%
1년 성능:
-24.98%
1일 변동 폭
$134.45
$139.96
1주일 범위
$134.45
$143.20
52주 변동 폭
$122.80
$219.34
Krystal Biotech Inc Stock (KRYS) Company Profile
명칭
Krystal Biotech Inc
전화
(412) 586-5830
주소
2100 WHARTON STREET, PITTSBURGH, PA
KRYS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
137.07 | 3.96B | 290.51M | 89.16M | 119.18M | 2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-05 | 개시 | Jefferies | Buy |
| 2024-08-06 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-11-20 | 개시 | Goldman | Buy |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-10-12 | 개시 | Citigroup | Buy |
| 2023-09-07 | 개시 | Berenberg | Buy |
| 2023-04-18 | 개시 | Stifel | Buy |
| 2023-02-28 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-08-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-01-18 | 개시 | BofA Securities | Buy |
| 2021-07-20 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-09-18 | 개시 | B. Riley FBR | Buy |
| 2020-06-04 | 개시 | Evercore ISI | Outperform |
| 2019-09-24 | 개시 | Goldman | Neutral |
| 2019-08-06 | 재확인 | H.C. Wainwright | Buy |
| 2019-06-24 | 재확인 | Chardan Capital Markets | Buy |
| 2019-06-24 | 재확인 | H.C. Wainwright | Buy |
| 2019-05-30 | 개시 | Guggenheim | Buy |
| 2018-09-11 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Krystal Biotech Inc 주식(KRYS)의 최신 뉴스
Krystal Biotech (NASDAQ:KRYS) and VectivBio (NASDAQ:VECT) Critical Review - Defense World
Cantor Fitzgerald Estimates Krystal Biotech FY2026 Earnings - Defense World
Krystal Biotech at Goldman Sachs Conference: Strategic Insights on VYJEVEC - Investing.com Canada
Why Is Krystal Biotech (KRYS) Down 3.5% Since Last Earnings Report? - Yahoo Finance
Exploring Three High Growth Tech Stocks In The US Market - simplywall.st
H.C. Wainwright maintains Krystal Biotech stock Buy rating at ASCO 2025 - Investing.com Nigeria
Krystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare Conference - The Manila Times
How To Trade (KRYS) - news.stocktradersdaily.com
Krystal Biotech Reports Promising Results for KB707 Trial - TipRanks
Implied Volatility Surging for Krystal Biotech Stock Options - Yahoo Finance
Head-To-Head Analysis: Genocea Biosciences (NASDAQ:GNCAQ) vs. Krystal Biotech (NASDAQ:KRYS) - Defense World
Krystal Biotech Enters Oversold Territory (KRYS) - Nasdaq
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Lazard Asset Management LLC Sells 922 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
D. E. Shaw & Co. Inc. Trims Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Why We're Not Concerned Yet About Krystal Biotech, Inc.'s (NASDAQ:KRYS) 26% Share Price Plunge - simplywall.st
Bank of America Corp DE Has $11.88 Million Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS) - Defense World
Krystal Biotech stock hits 52-week low at $127.33 By Investing.com - Investing.com South Africa
Krystal Biotech Holds Annual Stockholders Meeting - MSN
Krystal Biotech stock hits 52-week low at $127.33 - Investing.com
Krystal Biotech, Inc. (NASDAQ:KRYS) Position Cut by BNP Paribas Financial Markets - Defense World
Citigroup Lowers Krystal Biotech (NASDAQ:KRYS) Price Target to $155.00 - Defense World
Krystal Biotech (KRYS) Price Target Lowered by Citigroup | KRYS Stock News - GuruFocus
The Analyst Verdict: Krystal Biotech In The Eyes Of 12 Experts - Benzinga
Krystal Biotech (KRYS) Sees Price Target Cut Amid Sales Forecast Adjustment | KRYS Stock News - GuruFocus
H.C. Wainwright maintains Buy on Krystal Biotech shares By Investing.com - Investing.com Nigeria
Transcript : Krystal Biotech, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 11 - marketscreener.com
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore - MarketBeat
Krystal Biotech's (NASDAQ:KRYS) Solid Earnings Have Been Accounted For Conservatively - Yahoo Finance
Krystal Biotech Expands Gene Therapy Platform - TipRanks
How the (KRYS) price action is used to our Advantage - news.stocktradersdaily.com
FY2025 EPS Estimates for Krystal Biotech Lowered by Analyst - Defense World
Q4 EPS Estimates for Krystal Biotech Lifted by HC Wainwright - Defense World
Biotech Alert: Searches spiking for these stocks today - Yahoo Finance
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today - Benzinga
Krystal Biotech, Inc. (KRYS): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey
10 Best Cancer Stocks to Invest in for Long-Term Gains - Insider Monkey
H.C. Wainwright maintains Buy on Krystal Biotech shares - Investing.com Australia
Krystal Biotech, Inc. (KRYS) Misses Q1 Earnings and Revenue Estimates - MSN
Krystal Biotech "insulated" by domestic manufacturingPittsburgh Business Times - The Business Journals
Krystal Biotech (KRYS) Price Target Lowered by Guggenheim | KRYS Stock News - GuruFocus
Krystal Biotech (KRYS) Faces Hurdles After Lowered Price Target - GuruFocus
Krystal Biotech (KRYS) Faces Hurdles After Lowered Price Target | KRYS Stock News - GuruFocus
Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2025 Earnings Call Transcript - Insider Monkey
Krystal Biotech to Present at BofA Securities 2025 Health Care Conference - The Manila Times
Krystal Biotech (KRYS) Maintains Buy Rating and Price Target | KRYS Stock News - GuruFocus
Krystal Biotech Q1 Earnings and Sales Miss Estimates, Stock Down - MSN
Krystal Biotech Inc (KRYS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Krystal Biotech Inc (KRYS) Q1 2025 Earnings Call Highlights: Rec - GuruFocus
Earnings call transcript: Krystal Biotech misses Q1 2025 EPS forecast, stock drops 14% - Investing.com Nigeria
Krystal Biotech Inc (KRYS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.91%
1.17%
자본화:
|
볼륨(24시간):